- Home
- PMX vs DRTS Comparison
PMX vs DRTS Comparison
Compare PMX & DRTS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PMX
- DRTS
- Stock Information
- Founded
- PMX 2002
- DRTS 2015
- Country
- PMX United States
- DRTS Israel
- Employees
- PMX N/A
- DRTS N/A
- Industry
- PMX Trusts Except Educational Religious and Charitable
- DRTS Medical/Dental Instruments
- Sector
- PMX Finance
- DRTS Health Care
- Exchange
- PMX Nasdaq
- DRTS Nasdaq
- Market Cap
- PMX 243.2M
- DRTS 259.4M
- IPO Year
- PMX N/A
- DRTS N/A
- Fundamental
- Price
- PMX $7.46
- DRTS $2.70
- Analyst Decision
- PMX
- DRTS Strong Buy
- Analyst Count
- PMX 0
- DRTS 2
- Target Price
- PMX N/A
- DRTS $8.00
- AVG Volume (30 Days)
- PMX 101.5K
- DRTS 108.6K
- Earning Date
- PMX 01-01-0001
- DRTS 03-06-2025
- Dividend Yield
- PMX 5.28%
- DRTS N/A
- EPS Growth
- PMX N/A
- DRTS N/A
- EPS
- PMX N/A
- DRTS N/A
- Revenue
- PMX N/A
- DRTS N/A
- Revenue This Year
- PMX N/A
- DRTS N/A
- Revenue Next Year
- PMX N/A
- DRTS N/A
- P/E Ratio
- PMX N/A
- DRTS N/A
- Revenue Growth
- PMX N/A
- DRTS N/A
- 52 Week Low
- PMX $6.09
- DRTS $1.75
- 52 Week High
- PMX $8.47
- DRTS $4.39
- Technical
- Relative Strength Index (RSI)
- PMX 55.76
- DRTS 28.95
- Support Level
- PMX $7.35
- DRTS $2.95
- Resistance Level
- PMX $7.42
- DRTS $3.19
- Average True Range (ATR)
- PMX 0.08
- DRTS 0.21
- MACD
- PMX 0.01
- DRTS -0.08
- Stochastic Oscillator
- PMX 82.76
- DRTS 3.85
About PMX PIMCO Municipal Income Fund III of Beneficial Interest
PIMCO Municipal Income Fund III is a closed-end management investment company. Its investment objective is to seek to provide current income exempt from federal income tax. The fund portfolio of investments consists of investments in different sectors such as transportation, healthcare, and others.
About DRTS Alpha Tau Medical Ltd.
Alpha Tau Medical Ltd is a clinical-stage oncology therapeutics company focused on harnessing the innate relative biological effectiveness and short range of alpha particles for use as localized radiation therapy for solid tumors. The Alpha CaRT technology of the company utilizes the therapeutic properties of alpha particles aiming to overcome, and harness for benefit for alpha radiation's range. The company derives maximum revenue from Israel.